Search

Search Constraints

You searched for: Author/Creator Diculescu, Mircea

Search Results

1. Adding pegylated interferon to entecavir for hepatitis B e antigen–positive chronic hepatitis B: A multicenter randomized trial (ARES study). Issue 5 (27th February 2015)

3. COVID-19 and Inflammatory Bowel Diseases: Risk Assessment, Shared Molecular Pathways, and Therapeutic Challenges. (10th July 2020)

4. Long‐term follow‐up of patients treated with entecavir and peginterferon add‐on therapy for HBeAg‐positive chronic hepatitis B infection: ARES long‐term follow‐up. Issue 1 (27th September 2018)

5. OC-022 Endoscopy Pitfalls in Celiac Disease Diagnosis; a Multicentre Study. (4th June 2013)

6. Recurrence rate of hepatocellular carcinoma in patients with treated hepatocellular carcinoma and hepatitis C virus-associated cirrhosis after ombitasvir/paritaprevir/ritonavir+dasabuvir+ribavirin therapy. Issue 5 (June 2019)

7. Recurrence rate of hepatocellular carcinoma in patients with treated hepatocellular carcinoma and hepatitis C virus‐associated cirrhosis after ombitasvir/paritaprevir/ritonavir+dasabuvir+ribavirin therapy. Issue 5 (1st June 2019)

8. Subjective Global Assessment and Handgrip Strength as Predictive Factors in Patients with Liver Cirrhosis. (18th July 2017)

9. Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International Survey. Issue 6 (17th May 2021)